dc.contributor.author | Varshney, Mayank | |
dc.date.accessioned | 2024-05-01T05:45:45Z | |
dc.date.available | 2024-05-01T05:45:45Z | |
dc.date.issued | 2024-02-19 | |
dc.identifier.issn | 2059-5794 | |
dc.identifier.uri | http://hdl.handle.net/11718/27313 | |
dc.description.abstract | Technology acquisition is a common phenomenon of acquiring external knowledge, but we have a limited understanding of conditions in which the acquirer integrates the target or not. On one hand, the acquirer may have a policy to integrate the target to benefit from its prior knowledge. On the other hand, the target may face challenges in continuing its knowledge creation and the acquirer may want to provide it autonomy to not disrupt it. This paper aims to identify conditions in which targets tend to be less integrated after acquisitions, allowing them to maintain more autonomy and contribute more to knowledge creation. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Emerald Publishing Limited | en_US |
dc.relation.ispartof | Cross Cultural & Strategic Management | en_US |
dc.subject | Path dependence | en_US |
dc.subject | Cultural difference | en_US |
dc.subject | Technology acquisition | en_US |
dc.subject | Difference-in-difference | en_US |
dc.subject | Biopharmaceutical industry | en_US |
dc.subject | Structural difference | en_US |
dc.title | To integrate or not? Understanding knowledge integration of target firm | en_US |